1. Home
  2. MEI vs VERV Comparison

MEI vs VERV Comparison

Compare MEI & VERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MEI
  • VERV
  • Stock Information
  • Founded
  • MEI 1946
  • VERV 2018
  • Country
  • MEI United States
  • VERV United States
  • Employees
  • MEI N/A
  • VERV N/A
  • Industry
  • MEI Electrical Products
  • VERV Medicinal Chemicals and Botanical Products
  • Sector
  • MEI Technology
  • VERV Health Care
  • Exchange
  • MEI Nasdaq
  • VERV Nasdaq
  • Market Cap
  • MEI 402.1M
  • VERV 475.0M
  • IPO Year
  • MEI N/A
  • VERV 2021
  • Fundamental
  • Price
  • MEI $13.07
  • VERV $6.57
  • Analyst Decision
  • MEI Hold
  • VERV Strong Buy
  • Analyst Count
  • MEI 3
  • VERV 4
  • Target Price
  • MEI $14.00
  • VERV $25.75
  • AVG Volume (30 Days)
  • MEI 402.7K
  • VERV 1.4M
  • Earning Date
  • MEI 03-06-2025
  • VERV 02-25-2025
  • Dividend Yield
  • MEI 4.27%
  • VERV N/A
  • EPS Growth
  • MEI N/A
  • VERV N/A
  • EPS
  • MEI N/A
  • VERV N/A
  • Revenue
  • MEI $1,087,900,000.00
  • VERV $24,396,000.00
  • Revenue This Year
  • MEI N/A
  • VERV $97.47
  • Revenue Next Year
  • MEI $5.77
  • VERV N/A
  • P/E Ratio
  • MEI N/A
  • VERV N/A
  • Revenue Growth
  • MEI N/A
  • VERV 219.91
  • 52 Week Low
  • MEI $8.54
  • VERV $4.31
  • 52 Week High
  • MEI $22.20
  • VERV $19.34
  • Technical
  • Relative Strength Index (RSI)
  • MEI 61.84
  • VERV 58.47
  • Support Level
  • MEI $11.71
  • VERV $5.32
  • Resistance Level
  • MEI $12.31
  • VERV $6.87
  • Average True Range (ATR)
  • MEI 0.71
  • VERV 0.53
  • MACD
  • MEI 0.05
  • VERV 0.05
  • Stochastic Oscillator
  • MEI 97.34
  • VERV 80.71

About MEI Methode Electronics Inc.

Methode Electronics Inc makes component and subsystem devices employing electrical, radio remote control, electronic, wireless, and sensing technologies. The firm is organized into various business segments: Automotive, Industrial, Interface, and Medical. The Automotive segment which generates maximum revenue, supplies electronic and electro-mechanical devices and related products to automobiles. The products manufactured in the automotive segment include overhead and center consoles, hidden and ergonomic switches, insert molded components, LED-based lighting, and sensors. Geographically, the company generates maximum revenue from North America and the rest from Europe, the Middle East & Africa (EMEA), and Asia.

About VERV Verve Therapeutics Inc.

Verve Therapeutics Inc is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The company's initial two programs target PCSK9 and ANGPTL3, genes that have been extensively validated as targets for lowering blood lipids such as low-density lipoprotein cholesterol, a root cause of cardiovascular disease. The company views its operations as and manages its business in one operating segment operating exclusively in the United States.

Share on Social Networks: